Overview
Falcigo Plus Tablets are a fixed-dose combination of Artesunate (100 mg) and Mefloquine (200 mg), developed by Zydus Cadila. This combination is primarily used for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, especially in areas with known resistance to other antimalarial drugs. Artesunate, a derivative of artemisinin, acts rapidly to reduce the parasite load, while Mefloquine provides a long-acting effect to eliminate remaining parasites.





